Clostridium difficile caused almost half a million infections among patients in the United States in a single year, according to a new Centers for Disease Control and Prevention (CDC) study. C. difficile causes inflammation of the colon and deadly diarrhea.
CDC’s new study of data from 2011 found that:
- C. difficile infections cause immense suffering and death for thousands of Americans each year.
- An estimated 15,000 deaths are directly attributable to C. difficile infections, making it a substantial cause of infectious disease death in the United States.
- Risk of C. difficile infection and death increases with age. Thousands of C. difficile infections develop among residents of U.S. nursing homes each year, and a majority of the deaths associated with C. difficile occur among Americans 65 or older.
Previous studies indicate that C. difficile has become the most common pathogen identified as the cause of healthcare-associated infections in U.S. hospitals and costs up to $4.8 billion each year in excess healthcare costs for acute-care facilities alone. Taking antibiotics is the most important risk factor for developing C. difficile infections. These devastating infections can be avoided by improving antibiotic prescribing and infection control across our healthcare system.
Unnecessary antibiotic use in patients at one facility can cause spread of C. difficile in another facility when patients transfer. To help hospitals develop antibiotic prescribing improvement programs (also called antibiotic stewardship programs), the CDC has developed several tools, including a list of Core Elements of Hospital Antibiotic Stewardship Programs and an accompanying checklist.
Over the next five years, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria (CARB) will enhance national capabilities for antibiotic stewardship, outbreak surveillance, and antibiotic resistance prevention. These efforts hold the potential to cut the incidence of C. difficile infections in half.
Source: CDC
To access a slide show from ICT on this study, CLICK HERE.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
Robust infectious disease surveillance, including rapid subtyping of influenza A, is essential for early detection, containment, and public health reporting of novel viral threats.